134 related articles for article (PubMed ID: 31669265)
21. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation.
Moon B; Kwan JJ; Duddy N; Sweeney G; Begum N
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E106-15. PubMed ID: 12618360
[TBL] [Abstract][Full Text] [Related]
22. Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1.
Hopf AE; Andresen C; Kötter S; Isić M; Ulrich K; Sahin S; Bongardt S; Röll W; Drove F; Scheerer N; Vandekerckhove L; De Keulenaer GW; Hamdani N; Linke WA; Krüger M
Circ Res; 2018 Jul; 123(3):342-355. PubMed ID: 29760016
[TBL] [Abstract][Full Text] [Related]
23. Simvastatin inhibits glucose uptake activity and GLUT4 translocation through suppression of the IR/IRS-1/Akt signaling in C2C12 myotubes.
Li W; Liang X; Zeng Z; Yu K; Zhan S; Su Q; Yan Y; Mansai H; Qiao W; Yang Q; Qi Z; Huang Z
Biomed Pharmacother; 2016 Oct; 83():194-200. PubMed ID: 27470565
[TBL] [Abstract][Full Text] [Related]
24. AMPK activation by prolonged stimulation with interleukin-1β contributes to the promotion of GLUT4 translocation in skeletal muscle cells.
Takaguri A; Inoue S; Kubo T; Satoh K
Cell Biol Int; 2016 Nov; 40(11):1204-1211. PubMed ID: 27569904
[TBL] [Abstract][Full Text] [Related]
25. Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy.
Liu X; Gu X; Li Z; Li X; Li H; Chang J; Chen P; Jin J; Xi B; Chen D; Lai D; Graham RM; Zhou M
J Am Coll Cardiol; 2006 Oct; 48(7):1438-47. PubMed ID: 17010808
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.
Lu H; Buchan RJ; Cook SA
Cardiovasc Res; 2010 Jun; 86(3):410-20. PubMed ID: 20080987
[TBL] [Abstract][Full Text] [Related]
27. Effect of Three Statins on Glucose Uptake of Cardiomyocytes and its Mechanism.
Jiang Z; Yu B; Li Y
Med Sci Monit; 2016 Aug; 22():2825-30. PubMed ID: 27510725
[TBL] [Abstract][Full Text] [Related]
28. Over-expression of NYGGF4 (PID1) inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway.
Wu WL; Gan WH; Tong ML; Li XL; Dai JZ; Zhang CM; Guo XR
Mol Genet Metab; 2011 Mar; 102(3):374-7. PubMed ID: 21185755
[TBL] [Abstract][Full Text] [Related]
29. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
Li Z; Mei Y; Liu X; Zhou M
Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
[TBL] [Abstract][Full Text] [Related]
30. Insulin resistance in adult cardiomyocytes undergoing dedifferentiation: role of GLUT4 expression and translocation.
Rosenblatt-Velin N; Lerch R; Papageorgiou I; Montessuit C
FASEB J; 2004 May; 18(7):872-4. PubMed ID: 15117888
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel AS160 splice variant that regulates GLUT4 translocation and glucose-uptake in rat muscle cells.
Baus D; Heermeier K; De Hoop M; Metz-Weidmann C; Gassenhuber J; Dittrich W; Welte S; Tennagels N
Cell Signal; 2008 Dec; 20(12):2237-46. PubMed ID: 18771725
[TBL] [Abstract][Full Text] [Related]
32. Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
Mendes-Ferreira P; Maia-Rocha C; Adão R; Mendes MJ; Santos-Ribeiro D; Alves BS; Cerqueira RJ; Castro-Chaves P; Lourenço AP; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2016 Jan; 109(1):44-54. PubMed ID: 26503987
[TBL] [Abstract][Full Text] [Related]
33. Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking.
Ramírez E; Picatoste B; González-Bris A; Oteo M; Cruz F; Caro-Vadillo A; Egido J; Tuñón J; Morcillo MA; Lorenzo Ó
Cardiovasc Diabetol; 2018 Jan; 17(1):12. PubMed ID: 29325553
[TBL] [Abstract][Full Text] [Related]
34. Neuregulin-1/ErbB signaling and chronic heart failure.
Xu Y; Li X; Liu X; Zhou M
Adv Pharmacol; 2010; 59():31-51. PubMed ID: 20933198
[TBL] [Abstract][Full Text] [Related]
35. Nuclear receptor agonists improve insulin responsiveness in cultured cardiomyocytes through enhanced signaling and preserved cytoskeletal architecture.
Montessuit C; Papageorgiou I; Lerch R
Endocrinology; 2008 Mar; 149(3):1064-74. PubMed ID: 18063688
[TBL] [Abstract][Full Text] [Related]
36. An engineered bivalent neuregulin protects against doxorubicin-induced cardiotoxicity with reduced proneoplastic potential.
Jay SM; Murthy AC; Hawkins JF; Wortzel JR; Steinhauser ML; Alvarez LM; Gannon J; Macrae CA; Griffith LG; Lee RT
Circulation; 2013 Jul; 128(2):152-61. PubMed ID: 23757312
[TBL] [Abstract][Full Text] [Related]
37. NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
Baliga RR; Pimental DR; Zhao YY; Simmons WW; Marchionni MA; Sawyer DB; Kelly RA
Am J Physiol; 1999 Nov; 277(5):H2026-37. PubMed ID: 10564160
[TBL] [Abstract][Full Text] [Related]
38. Arsenite modulates cardiac substrate preference by translocation of GLUT4, but not CD36, independent of mitogen-activated protein kinase signaling.
Luiken JJ; Momken I; Habets DD; El Hasnaoui M; Coumans WA; Koonen DP; Glatz JF; Bonen A
Endocrinology; 2006 Nov; 147(11):5205-16. PubMed ID: 17038550
[TBL] [Abstract][Full Text] [Related]
39. Insulin-stimulated cytosol alkalinization facilitates optimal activation of glucose transport in cardiomyocytes.
Yang J; Gillingham AK; Hodel A; Koumanov F; Woodward B; Holman GD
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1299-307. PubMed ID: 12388133
[TBL] [Abstract][Full Text] [Related]
40. miR-150 regulates glucose utilization through targeting GLUT4 in insulin-resistant cardiomyocytes.
Ju J; Xiao D; Shen N; Zhou T; Che H; Li X; Zhang S; Mokembo JN; Jha NK; Monayo SM; Wang Z; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1111-1119. PubMed ID: 33085741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
